Gilla Kaplan - Net Worth and Insider Trading
Gilla Kaplan Net Worth
The estimated net worth of Gilla Kaplan is at least $9 Million dollars as of 2026-09-11. Gilla Kaplan is the Director of Celgene Corp and owns about 76,301 shares of Celgene Corp (CELG) stock worth over $8 Million. Gilla Kaplan is also the Director of Tyra Biosciences Inc and owns about 28,231 shares of Tyra Biosciences Inc (TYRA) stock worth over $664,558. Details can be seen in Gilla Kaplan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gilla Kaplan has not made any transactions after 2026-03-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gilla Kaplan
Gilla Kaplan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gilla Kaplan owns 2 companies in total, including Avalo Therapeutics Inc (AVTX) , and Tyra Biosciences Inc (TYRA) .
Click here to see the complete history of Gilla Kaplan’s form 4 insider trades.
Insider Ownership Summary of Gilla Kaplan
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2021-12-31 | director |
| TYRA | Tyra Biosciences Inc | 2026-03-25 | director |
Gilla Kaplan Latest Holdings Summary
Gilla Kaplan currently owns a total of 2 stocks. Among these stocks, Gilla Kaplan owns 76,301 shares of Celgene Corp (CELG) as of May 18, 2018, with a value of $8 Million and a weighting of 92.55%. Gilla Kaplan also owns 28,231 shares of Tyra Biosciences Inc (TYRA) as of March 25, 2026, with a value of $664,558 and a weighting of 7.45%.
Latest Holdings of Gilla Kaplan
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CELG | Celgene Corp | 2018-05-18 | 76,301 | 108.24 | 8,258,820 |
| TYRA | Tyra Biosciences Inc | 2026-03-25 | 28,231 | 23.54 | 664,558 |
Holding Weightings of Gilla Kaplan
Gilla Kaplan Form 4 Trading Tracker
According to the SEC Form 4 filings, Gilla Kaplan has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 27,750 shares on May 18, 2018, which brought Gilla Kaplan around $2 Million.
According to the SEC Form 4 filings, Gilla Kaplan has made a total of 3 transactions in Tyra Biosciences Inc (TYRA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Tyra Biosciences Inc is the sale of 14,295 shares on March 25, 2026, which brought Gilla Kaplan around $528,486.
Insider Trading History of Gilla Kaplan
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Gilla Kaplan Trading Performance
Gilla Kaplan Ownership Network
Ownership Network List of Gilla Kaplan
Ownership Network Relation of Gilla Kaplan
Gilla Kaplan Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Gilla Kaplan is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include Chief Medical Officer Mittie Doyle , Interim CFO Christopher Ryan Sullivan , and Chief Strategy Officer Jennifer Riley .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Gilla Kaplan made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net sale of 151,516 shares made by Mittie Doyle , a net sale of 171,205 shares made by Christopher Ryan Sullivan , and a net sale of 75,063 shares made by Paul Varki .
In summary, during the past 3 months, insiders sold 84,842 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 84,842 shares. During the past 18 months, 414,973 shares of Avalo Therapeutics Inc (AVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 414,973 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Gilla Kaplan Mailing Address
Above is the net worth, insider trading, and ownership report for Gilla Kaplan. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Gilla Kaplan's mailing address is: Wayne Pa 19087.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
